Janux Therapeutics Inc (JANX)
47.11
-0.40
(-0.84%)
USD |
NASDAQ |
May 17, 16:00
47.11
0.00 (0.00%)
After-Hours: 20:00
Janux Therapeutics Accounts Payable (Quarterly): 2.254M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.254M |
| December 31, 2023 | 2.424M |
| September 30, 2023 | 2.505M |
| June 30, 2023 | 1.91M |
| March 31, 2023 | 2.051M |
| December 31, 2022 | 2.159M |
| September 30, 2022 | 2.866M |
| Date | Value |
|---|---|
| June 30, 2022 | 3.00M |
| March 31, 2022 | 1.939M |
| December 31, 2021 | 2.458M |
| September 30, 2021 | 3.613M |
| June 30, 2021 | 0.354M |
| March 31, 2021 | 0.857M |
| December 31, 2020 | 0.428M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.354M
Minimum
Jun 2021
3.613M
Maximum
Sep 2021
2.058M
Average
2.206M
Median
Accounts Payable (Quarterly) Benchmarks
| Viking Therapeutics Inc | 5.225M |
| Equillium Inc | 2.778M |
| Minerva Neurosciences Inc | 1.436M |
| Arvinas Inc | 17.80M |
| Calidi Biotherapeutics Inc | 2.877M |